A review warns against delaying or ignoring the concerns of individuals with chronic pain during the coronavirus disease 2019 (COVID-19) pandemic.
While sheltering-in-place and social distancing are vital to limit the spread of coronavirus disease 2019 (COVID-19), those necessary measures may have consequences for patients with chronic pain, according to a recent review.
In addition, patients who recover from COVID-19 but still have lingering pain or heightened pain sensitivity (including myalgias, referred pain, and widespread hyperalgesia) may also be affected by the changes taking place in health care delivery.
Moreover, pain specialists are aware of the biopsychosocial model of pain, which may carry greater weight during this time of COVID-19, as it stresses the intersection of the patient‘s biological, psychological, and social factors.
Ignoring the concerns of individuals with chronic pain, many of which existed before the pandemic, carries certain risks, including “deconditioning, increased mental health concerns, financial burdens, and potential for medication-induced immune-suppression,” according to the authors. Treatment interruptions or delays could have future effects, worsening mental health and substance use disorders, as well as increased future health care spending.
Pre-existing problems include opioid overuse, the rising use of surgery for some procedures that may not be significantly better than rehabilitation, and a lack of education.
Patients who relied on physical therapy or exercise for pain management may have seen a reduction in activity as a result of stay-at-home orders and various closures.
However, the increased use of telemedicine is one bright spot for these patients, who should be engaged in shared decision making, the authors said. Telemedicine could include ongoing services, assessments, treatment, and follow-up.
The review authors suggested 5 factors providers should take into account when treating patients with chronic pain:
They also encouraged the use of validated pain assessment tools and scales as well as chronic pain clinics.
For the management of pain linked to COVID-19, the authors said that providers should avoid corticosteroids if a patient has COVID-19 infection, even if asymptomatic.
Pain that was present before COVID-19 may be exaggerated; milder pain symptoms associated with COVID-19 can be relieved with acetaminophen and NSAIDs.
For moderate to severe chronic malignant pain, the review recommended opioids with minimal immunosuppression effects, such as buprenorphine.
Reference
El-Tallawy SN, Nalamasu R, Pergolizzi JV, Gharibo C. Pain management during the COVID-19 pandemic. Pain Ther. Published online August 25, 2020. doi: 10.1007/s40122-020-00190-4
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
A new federal rule will enable thousands of immigrants in the Deferred Action for Childhood Arrivals (DACA) program to obtain health care through the Affordable Care Act; a forthcoming CMS rule is expected to lower home-based care wait times and raise caregiver wages; the HHS Office for Civil Rights has finalized 2 rules that strengthen the ACA’s health care discrimination ban.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Initiating BP Medication Linked to Higher Fall, Fracture Risks in Nursing Home Residents
May 2nd 2024Among over 60,000 nursing home residents who initiated antihypertensive medication, rates of excess fractures due to falls per 100 person-years were as high as 5 among certain patient groups, such as those with dementia and high blood pressure (BP).
Read More